摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴-2-乙氧基-1-氟苯 | 900174-64-3

中文名称
4-溴-2-乙氧基-1-氟苯
中文别名
2-氟-5-溴苯乙醚
英文名称
4-bromo-2-ethoxy-1-fluorobenzene
英文别名
——
4-溴-2-乙氧基-1-氟苯化学式
CAS
900174-64-3
化学式
C8H8BrFO
mdl
——
分子量
219.053
InChiKey
QNMCMYYZINDARU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    224.9±20.0 °C(Predicted)
  • 密度:
    1.457±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:b79e34b7d824ba803ea6cc9b228dbfe2
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-溴-2-乙氧基-1-氟苯 在 AtH2(1+)*HO(1-)叔丁基锂N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下, 以 四氢呋喃N,N-二甲基甲酰胺正戊烷 为溶剂, 反应 16.25h, 生成 N-(3-ethoxy-4-fluorobenzoyl)-D-serine methyl ester
    参考文献:
    名称:
    Potent, Novel in Vitro Inhibitors of the Pseudomonas aeruginosa Deacetylase LpxC
    摘要:
    Deacetylation of uridyldiphospho-3-O-(R-hydroxydecanoyl)-N-acetylglucosamine by LpxC is the first committed step in the Pseudomonas aeruginosa biosynthetic pathway to lipid A; homologous enzymes are found widely among Gram-negative bacteria. As an essential enzyme for which no inhibitors have yet been reported, the P. aeruginosa LpxC represents a highly attractive target for a novel antibacterial drug. We synthesized several focused small-molecule libraries, each composed of a variable aromatic ring, one of four heterocyclic/spacer moieties, and a hydroxamic acid and evaluated the LpxC inhibition of these compounds against purified P. aeruginosa enzyme. To ensure that the in vitro assay would be as physiologically relevant as possible, we synthesized a tritiated form of the specific P. aeruginosa glycolipid substrate and measured directly the enzymatically released acetate. Several of our novel compounds, predominantly those having fluorinated substituents on the aromatic ring and an oxazoline as the heterocyclic moiety, demonstrated in vitro IC50 values less than 1 muM. We now report the synthesis and in vitro evaluation of these P. aeruginosa LpxC inhibitors.
    DOI:
    10.1021/jm010579r
  • 作为产物:
    描述:
    碘乙烷5-溴-2-氟苯酚potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以77%的产率得到4-溴-2-乙氧基-1-氟苯
    参考文献:
    名称:
    BENZAMIDE FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS
    摘要:
    本发明提供了式(I)的新型苯甲酰胺衍生物:或其立体异构体、互变异构体、药学上可接受的盐、溶剂合物或前药,其中变量A、W、Y、Z、R8和R9如本文所定义。这些化合物是选择性因子VIIa的抑制剂,可用作药物。
    公开号:
    US20100227894A1
点击查看最新优质反应信息

文献信息

  • Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
    申请人:Zhang Xiaojun
    公开号:US20070003539A1
    公开(公告)日:2007-01-04
    The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W 1 , Y, Z, R 7 , R 8 , R 9 , and R 11 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.
    本发明提供了式(I)或(IV)的新型苯基甘氨酰衍生物:或其立体异构体、互变异构体、药学上可接受的盐、溶剂合物或前药,其中变量W、W1、Y、Z、R7、R8、R9和R11如本文所定义。这些化合物是选择性因子VIIa的抑制剂,可用作药物。
  • Phenylglycinamide derivatives useful as anticoagulants
    申请人:Zhang Xiaojun
    公开号:US20060166997A1
    公开(公告)日:2006-07-27
    The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
    本发明一般涉及抑制丝氨酸蛋白酶的苯基甘氨酰衍生物。具体而言,本发明涉及新型苯基甘氨酰衍生物及其类似物,其可用作凝血级联反应的丝氨酸蛋白酶酶的选择性抑制剂;例如凝血酶、第VIIa因子、第Xa因子、第XIa因子、第IXa因子和/或血浆激肽。特别是,它涉及到的化合物是第VIIa因子的抑制剂。本发明还涉及包含这些化合物的制药组合物及其使用方法。
  • AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS AS BETA-SECRETASE INHIBITORS
    申请人:Malamas Michael Sotirios
    公开号:US20090042964A1
    公开(公告)日:2009-02-12
    The present invention provides a 2-amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compound of formula I The present invention also provides methods for the use thereof to inhibit β-secretase (BACE) and treat β-amyloid deposits and neurofibrillary tangles.
    本发明提供了一种公式I的2-氨基-5-[取代的4-(二氟甲氧基)苯基]-5-苯基咪唑酮化合物。本发明还提供了使用该化合物的方法,以抑制β-分泌酶(BACE)并治疗β-淀粉样沉积和神经原纤维缠结。
  • Benzamide factor VIIa inhibitors useful as anticoagulants
    申请人:Bristol-Myers Squibb Company
    公开号:US08222453B2
    公开(公告)日:2012-07-17
    The present invention provides novel benzamide derivatives of Formula (I): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables A, W, Y, Z, R8, and R9 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.
    本发明提供一种新的苯甲酰胺衍生物,其化学式为(I):或其立体异构体、互变异构体、药学上可接受的盐、溶剂化合物或前药,其中变量A、W、Y、Z、R8和R9如本文所定义。这些化合物是选择性因子VIIa抑制剂,可用作药物。
  • WO2006/76246
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多